Loraz and Kineret drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Loraz (lorazepam) and Kineret (anakinra). Common drug interactions include pyrexia among females and left ventricular hypertrophy among males.

The phase IV clinical study analyzes what interactions people have when they take Loraz and Kineret. It is created by eHealthMe based on reports of 47 people who take the same drugs from the FDA, and is updated regularly.

What is Loraz?

Loraz has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,695 Loraz users. Check the latest studies of Loraz.

What is Kineret?

Kineret has active ingredients of anakinra. It is often used in rheumatoid arthritis. eHealthMe is studying from 11,120 Kineret users. Check the latest studies of Kineret.

On Aug, 12, 2026

47 people who take Loraz and Kineret together, and have interactions are studied.

What are the common drug interactions of Loraz and Kineret, by gender? *:

female:

Pyrexia (fever)
Spinal osteoarthritis (joint cartilage loss in spine)
Vaginal candidiasis (vaginal fungal infection)
Vaginal cyst
Visual disturbance
Vomiting
Sepsis (a severe blood infection that can lead to organ failure and death)
White blood cell count decreased
Balance disorder
Bronchial hyperreactivity

male:

Left ventricular hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart)
Abdominal infection
Blood calcium decreased
Blood chloride increased
Blood creatinine decreased
Blood fibrinogen decreased
Blood glucose increased
Blood lactate dehydrogenase increased
Blood magnesium increased
Blood phosphorus decreased

What are the common drug interactions of Loraz and Kineret, by age (0-1 to 60+)? *:

0-1:

Abdominal infection
Activated partial thromboplastin time prolonged
Alanine aminotransferase increased
Ammonia decreased
Anaemia (lack of blood)
Anion gap increased
Aspartate aminotransferase increased
Blast cell count increased
Blood albumin decreased
Blood calcium decreased

2-9:

Left ventricular hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart)

10-19:

n/a

20-29:

Injection site urticaria (rash of round, red welts on the skin at injection site)

30-39:

Malaise (a feeling of general discomfort or uneasiness)
Abdominal pain
Arthralgia (joint pain)
Asthenia (weakness)
C-reactive protein increased
Chest pain
Drug ineffective
Fatigue (feeling of tiredness)
Head injury
Injection site reaction

40-49:

Interstitial lung disease
Erectile dysfunction
Fungal infection
Headache (pain in head)
Injection site pain
Injection site pruritus (severe itching at injection site)
Injection site urticaria (rash of round, red welts on the skin at injection site)
Pain
Peripheral neuropathy (damage to nerves of the peripheral nervous system)
Rash

50-59:

Pulmonary embolism (blockage of the main artery of the lung)
Tuberculosis (a bacterial infection by mycobacterium tuberculosis)
Klebsiella infection
Leg ulcer (excl varicose) (leg ulcer without varicose vein)
Night sweats (sweating in night)
Pleural effusion (water on the lungs)
Urinary tract infection
Drug effect decreased
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)

60+:

Dehydration (dryness resulting from the removal of water)
Nausea (feeling of having an urge to vomit)
Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
Drug ineffective
Joint swelling
Lung nodule (solid, raised areas in lung)
Peripheral swelling
Pyelonephritis (inflammation of kidney caused by bacteria)
Pyrexia (fever)
Sepsis (a severe blood infection that can lead to organ failure and death)

* Approximation only. Some reports may have incomplete information.

Do you take Loraz and Kineret?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously